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A20 is an anti-inflammatory protein linked to multiple
human autoimmune diseases and lymphomas. A20
possesses a deubiquitinating motif and a zinc finger,
ZF4, that binds ubiquitin and supports its E3 ubiqui-
tin ligase activity. To understand how these activities
mediate A20’s physiological functions, we generated
two lines of gene-targeted mice, abrogating either
A20’s deubiquitinating activity (Tnfaip3OTU mice) or
A20’s ZF4 (Tnfaip3ZF4 mice). Both Tnfaip3OTU and
Tnfaip3ZF4 mice exhibited increased responses to
TNF and sensitivity to colitis. A20’s C103 deubiquiti-
nating motif restricted both K48- and K63-linked
ubiquitination of receptor interacting protein 1
(RIP1). A20’s ZF4 was required for recruiting A20
to ubiquitinated RIP1. A20OTU proteins and A20ZF4
proteins complemented each other to regulate RIP1
ubiquitination and NFkB signaling normally in com-
poundmutant Tnfaip3OTU/ZF4 cells. This complemen-
tation involved homodimerization of A20 proteins,
and we have defined an extensive dimerization inter-
face in A20. These studies reveal how A20 proteins
collaborate to restrict TNF signaling.
INTRODUCTION
Ubiquitination has emerged as a potent and complex mecha-
nism for regulating cell signaling (Pickart and Fushman, 2004).
Attachment of either single ubiquitin molecules or polymeric
ubiquitin chains to signaling proteins induces their association
with degradative proteasomes, lysosomal compartments, or
other proteins that propagate signals toward nuclear transcrip-
tion factors (Chen and Sun, 2009). These diverse outcomes are
largely specified by polyubiquitin chains whose units are poly-
merized via epsilon amino groups of distinct lysine residues (or
the N-terminal amino group) on ubiquitin (e.g., K11, K48, K63).
Distinct types of polyubiquitin chains can be recognized by ubiq-
uitin binding proteins via combinations of a variety of ubiquitin
interacting motifs (Sims et al., 2009, Sims and Cohen, 2009).
Unanchored ubiquitin chains, chains that are not covalently
attached to signaling proteins, are also important in the propaga-
tion of signaling (Xia et al., 2009). Ubiquitination events are regu-896 Immunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc.lated by enzymes that orchestrate the attachment or removal of
ubiquitin chains from proteins. Ubiquitin chains are built with
combinations of E1, E2, and E3 enzymes, whereas these chains
are degraded or removed by deubiquitinating enzymes (DUBs).
Although these broad outlines of ubiquitination have been partly
dissected in cell-free studies, the mechanisms by which ubiqui-
tin-modifying enzymes recognize and modify ubiquitinated
signaling complexes and how their functions are integrated in
cells are poorly understood.
A20 is a potent regulator of several innate immune signals,
including tumor necrosis factor (TNF), Toll-like receptor (TLR),
nucleotide oligomerizatin domain (NOD)-containing proteins,
and CD40 triggered NF-kB signals (Opipari et al., 1990, Lee
et al., 2000, Boone et al., 2004, Hitotsumatsu et al., 2008,
Tavares et al., 2010). A20 protein is encoded by the Tnfaip3
gene. A20-deficient (Tnfaip3/) mice develop spontaneous
inflammation and perinatal lethality, which is largely abrogated
by elimination of MyD88 adaptor-dependent signals (Lee et al.,
2000, Turer et al., 2008). Single nucleotide polymorphisms
(SNPs) of the human TNFAIP3 gene are strongly linked to sus-
ceptibility to rheumatoid arthritis, systemic lupus erythematosus,
and psoriasis, as well asmultiple other inflammatory and autoim-
mune diseases (Plenge et al., 2007, Thomson et al., 2007,
Musone et al., 2008, Graham et al., 2008, Nair et al., 2009, Ma
and Malynn, 2012). In addition, biallelic mutations of this gene
are pathogenetic in a variety of human lymphomas (Compagno
et al., 2009, Kato et al., 2009, Malynn and Ma, 2009). Hence,
the biological and clinical functions of this protein are of great
interest.
In vitro studies suggest that A20 restricts NF-kB signals via
deubiquitinating (DUB) activity, ubiquitin binding activity, and/or
E3 ligase activity (Wertz et al., 2004; Bosanac et al., 2010). The
N terminus of A20 contains an ovarian tumor (OTU) domain
that mediates its DUB activity. A20’s C103 based DUB activity
preferentially cleaves K11, K48, and/or K63-linked ubiquitin
chains, but not linear ubiquitin chains (Boone et al., 2004, Wertz
et al., 2004, Bosanac et al., 2010, Lin et al., 2008, Komander and
Barford, 2008). A20 appears to remove K63 chains from receptor
interacting protein 1 (RIP1) and TNF receptor-associated factor 6
(TRAF6), providing potential mechanisms for how A20 may
restrict signaling pathways utilizing these proteins (Boone
et al., 2004, Wertz et al., 2004; Lin et al., 2008, Komander and
Barford, 2008). A20 may also utilize its C103 DUBmotif to inhibit
E2-E3 enzyme interactions, thereby limiting synthesis of ubiqui-
tin chains (Shembade et al., 2010). However, studies with
N-terminal A20 constructs containing the C103 motif suggests
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ZF4-Dependent Recruitment of A20 Dimersthat this half of the protein does not restrict TNF-induced NF-kB
signaling (Heyninck and Beyaert, 1999). In addition, none of
these studies utilized cells bearing physiologically expressed
A20 protein. Thus, the physiological roles of A20’s DUB activity
in restricting NF-kB signals are unclear.
The C-terminal half of the A20 protein contains seven zinc fin-
gers. The fourth finger, ZF4, has been shown to bind ubiquitin
chains and support E3 ligase activity (Wertz et al., 2004, Bosanac
et al., 2010). Ubiquitin binding by this motif resembles ubiquitin
binding by a similar zinc finger in the E3 ubiquitin ligase Rabex
5, a guanine nucleotide exchange factor (Lee et al., 2006,
Penengo et al., 2006, Mattera et al., 2006). A20’s ZF4-based
E3 ligase activity may support K48 ubiquitination of RIP1 or ubiq-
uitination of E2 enzymes such as ubiquitin conjugating enzyme-5
(Ubc5) or Ubc13 (Wertz et al., 2004, Shembade et al., 2010). The
localization of both ubiquitin binding and E3 ligase activity to ZF4
suggests that these functions are intimately related; however,
this relationship is incompletely understood. Moreover, as with
A20’s C103-based deubiquitination, the physiological functions
of the ZF4 motif and its relationship to A20’s C103 have not
been investigated in vivo.
A20 expression is dynamically induced by NF-kB-dependent
signals, and A20 expression is precisely regulated to maintain
cellular homeostasis (Krikos et al., 1992, Lee et al., 2000). Pro-
gressively higher heterologous A20 expression inhibits TNF-
induced NF-kB signaling in a dose-dependent fashion, and
hypomorphic expression of endogenous A20 renders murine
cells hypersensitive to various ligands (Werner et al., 2008,
Tavares et al., 2010, Hammer et al., 2011). Hypomorphic
expression or function of A20 may also confer susceptibility to
human disease (Musone et al., 2008, Adrianto et al., 2011).
Hence, to define the physiological functions of A20’s ubiquitin
modifying functions, we have generated gene-targeted mice
bearing either a point mutation that abrogates A20’s DUB activ-
ity or point mutations that abrogate A20’s ZF4 based E3 ligase
or ubiquitin binding activity. These gene targeted mice should
express A20 at physiological and properly regulated expression
amounts. We have used these mice to determine the physiolog-
ical functions of these motifs in regulating innate immune
signals.
RESULTS
Generation of Tnfaip3OTU and Tnfaip3ZF4 Mice
To determine the physiological functions of A20’s DUB activity,
we recombineered a gene targeting construct encoding a
cysteine-to-alanine mutation at amino acid residue 103, the
catalytic cysteine in A20’s OTU domain required for its deubiqui-
tinating function, and an intronic LoxP-flanked neomycin selec-
tion cassette (see Figure S1A available online) (Boone et al.,
2004; Wertz et al., 2004, Lin et al., 2008, Komander and Barford,
2008). This construct was introduced into PRXB6T (C57BL/6J
inbred) embryonic stem cells (ESCs). After identification of prop-
erly targeted ESCs that underwent homologous recombination,
LoxP-flanked neomycin sequences were deleted in vitro by
transfection with a Cre expression construct. Selected ESCs
bearing the C103A point mutation and lacking the neomycin
cassette were then used to generate germline mice, hereafter
referred to as Tnfaip3OTU mice.To abrogate A20’s ZF4-based E3 ligase and ubiquitin binding
activity, we generated a second construct encoding tandem
cysteine-to-alanine point mutations in this motif: Cys 609 and
Cys 613. These mutations abrogate A20’s E3 ligase activity
(Wertz et al., 2004). This construct was also introduced into
PRXB6T ESCs, targeted ESCs were selected, Cre-mediated
removal of the LoxP-neomycin cassette was performed
in vitro, and the final selected ESCs bearing the ZF4 tandem
point mutations were used to generate Tnfaip3ZF4 mice
(Figure S1B).
In contrast to Tnfaip3/mice that develop perinatal cachexia
and lethality, homozygous Tnfaip3OTU/OTU and Tnfaip3ZF4/ZF4
mice were both grossly normal for at least 4 months of life
(data not shown). Thus, neither A20’s C103 nor its ZF4 motifs
are required for preventing spontaneous cachexia and prema-
ture death. Flow cytometric analyses of lymphoid tissues from
2-month-old mice revealed that both Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 mice contained normal numbers of lymphocytes
(data not shown). As these mice age to 6 months, they gradually
developed splenomegaly and accumulated modestly increased
numbers of myeloid cells and lymphocytes, suggesting that both
A20’s C103 and ZF4 motifs regulate immune homeostasis
(Figure 1A).
A20 is an inducible molecule that may be particularly impor-
tant for restricting inflammatory signals. Accordingly, we chal-
lenged Tnfaip3OTU/OTU and A20ZF4/ZF4 mice with oral dextran
sulfate sodium (DSS). DSS treatment caused greater intestinal
inflammation in both Tnfaip3OTU/OTU and A20ZF4/ZF4 mice
compared to wild-type (WT) control mice, as measured by a
combinatorial histological score (Figure 1B). Both mutant mice
strains also induced greater expression of interleukin-1 (IL-1)
and IL-6, but not TNF, in intestinal tissues (Figure 1C). Thus,
both A20’s C103 and ZF4motifs restrict inflammatory responses
in vivo.
A20’s C103 and ZF4 Motifs Restrict TNF Responses
Because A20 regulates TNF signals, we examined the role of
A20’s C103 and ZF4 motifs in regulating TNF responses. Injec-
tion of a sublethal dose of TNF into Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 mice induced greater amounts of serum IL-6
and monocyte chemotactic protein-1 (MCP-1) than in control
mice, suggesting that both C103 and ZF4 are required for re-
stricting TNF responses in vivo (Figure 2A). To more directly
determine how these motifs restrict TNF signals, we stimulated
embryonic fibroblasts (MEFs) from Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 mice with TNF in vitro. Both Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 cells produced elevated amounts of the NF-kB
dependent IL-6 and A20 messenger RNAs (mRNAs) within 1 hr
of TNF stimulation, consistent with increased NF-kB signaling
in these cells (Figure 2B). The amounts of A20 protein were
induced by TNF to a greater degree in Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 cells than control cells, suggesting that increased
Tnfaip3 mRNA in these cells led to increased A20 protein (Fig-
ure 2C). Moreover, these results suggest that both A20OTU and
A20ZF4 mutant proteins are similarly stable as WT A20 protein.
The relative amounts of NF-kB dependent mRNAs produced
by these cells correlated with the degree of NF-kB signaling re-
flected by phospho-IkBa and IkBa protein amounts, as well as
IKK kinase assays (Figures 2C and 2D). Tnfaip3OTU/OTU andImmunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc. 897
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Figure 1. Tnfaip3OTU/OTU and Tnfaip3ZF4/ZF4
Mice Exhibit Mild Immune Dysplasia with
Age and Fail to Restrict Inflammation in
DSS Colitis
(A) Flow cytometric quantitation of splenic T (CD4+
and CD8+), B (CD19+), and myeloid (CD11b+) cells
from older (6-month-old) mice of indicated geno-
types. Data are representative of three to four mice
per genotype.
(B and C) DSS responses of young adult
(2-month-old) Tnfaip3OTU/OTU and Tnfaip3ZF4/ZF4
mice. (B) Hematoxylin eosin stain of colon sections
and computed histological scores of WT,
Tnfaip3OTU/OTU, and Tnfaip3ZF4/ZF4 mice treated
with 3% oral DSS for 5 days. (C) Quantitative PCR
(qPCR) analyses of expression of indicated cyto-
kine mRNAs, normalized to actin mRNA, from
intestinal tissues of the samemice described in (B).
* indicates p < 0.05 by ANOVA. Error bars repre-
sent means and SD. Significant (p < 0.05) differ-
ences noted in between WT and mutant cells in
IL-6 and IL-1b but not TNF production. Data are
representative of three independent experiments
using at least three mice per genotype. See also
Figure S1.
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ZF4-Dependent Recruitment of A20 DimersTnfaip3ZF4/ZF4 cells produced less of the NF-kB-dependent
mRNAs IL-6 and cellular inhibitor of apoptosis protein 2
(cIAP2), and exhibited less NF-kB signaling than Tnfaip3/
cells, suggesting that neither A20’s C103 motif nor its ZF4 motif
are singly responsible for all of A20’s functions during TNF
signaling (Figures S2A and S2B). Immunoblotting studies of
pJNK, p38, and pERK kinase signaling revealed normal signaling
activity in Tnfaip3OTU/OTU and Tnfaip3ZF4/ZF4 cells (Figure 2E).
Thus, A20’s C103 and ZF4 motifs regulate TNF responses by
regulating the kinetics of NF-kB signaling.
RIP1 ubiquitination supports TNF-induced NF-kB signaling,
and A20 restricts RIP1 ubiquitination (Ea et al., 2006, Wu et al.,
2006, Wertz et al., 2004). Accordingly, we measured TNF recep-
tor (TNFR)-induced RIP1 ubiquitination in Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 cells by immunoprecipitating TNFR complexes
and immunoblotting for RIP1. Greater amounts of ubiquitinated
RIP1 were associated with TNFR1 in both Tnfaip3OTU/OTU and
Tnfaip3ZF4/ZF4 cells compared to WT cells 10 and 15 min after
TNF treatment (Figure 3A; Figure S2C). As distinct types of
ubiquitin chains are associated with diverse outcomes of modi-
fied proteins, and as A20 has been shown to restrict K63-linked
polyubiquitin chains and build K48 chains, our results raised
the question of what types of ubiquitin chains are present on
RIP1 in these cells. We characterized the ubiquitin chains on
TNFR associated RIP1 molecules by performing serial TNFR
and RIP1 immunoprecipitations (IPs) on TNF stimulated cells fol-
lowed by immunoblotting with ubiquitin linkage-specific
antibodies. These studies revealed that both Tnfaip3OTU/OTU
and Tnfaip3ZF4/ZF4 cells contained increased amounts of both
K48 and K63-linked ubiquitin chains on RIP1 molecules898 Immunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc.(Figure 3B). These results suggest that
A20’s C103 deubiquitinating motif re-
stricts both K48 and K63-linked ubiquiti-
nation of RIP1.Because A20’s ZF4 motif has been proposed to ligate K48-
ubiquitin chains to RIP1, the presence of increased ubiquiti-
nated RIP1 in A20ZF4/ZF4 cells could be explained by decreased
ubiquitin mediated turnover of RIP1 proteins in these cells
(Wertz et al., 2004). We thus assayed RIP1 ubiquitination of
TNF stimulated cells in the presence of the proteasome
inhibitor MG-132. These experiments revealed that both
Tnfaip3OTU/OTU and Tnfaip3ZF4/ZF4 cells continued to exhibit
increased RIP1 ubiquitination (Figure 3C). Thus, A20’s ZF4
motif is unexpectedly required for restricting TNF induced
RIP1 ubiquitination.
A20’s ZF4 Motif Recruits A20 to Ubiquitinated RIP1 in
TNFR Signaling Complexes
Increased ubiquitination of RIP1 in A20ZF4/ZF4 cells is not readily
explained by a reduction in A20’s ZF4 based ligation of ubiquitin
chains on RIP1. We thus investigated alternative mechanisms
by which mutation of A20’s ZF4 might cause increased RIP1
ubiquitination. A20’s ZF4 resembles a zinc finger in Rabex-5
that binds ubiquitin, and ZF4 directly binds ubiquitin chains
(Lee et al., 2006, Penengo et al., 2006, Mattera et al., 2006, Bo-
sanac et al., 2010). Accordingly, we asked whether our ZF4 mu-
tation abrogates A20’s ability to bind ubiquitin. Binding studies
with recombinant C-terminal A20 proteins and ubiquitin chains
demonstrated that A20 binds K63-linked ubiquitin chains and
that the dual cysteine-to-alanine substitutions we generated in
A20’s ZF4 motif (A20ZF4 proteins) eliminated A20’s ability to
bind these chains (Figure 4A). To determine whether this ubiqui-
tin-binding activity is important for A20’s ability to bind physio-
logically ubiquitinated RIP1 proteins, we incubated lysates from
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Figure 2. A20’s OTU and ZF4 Motifs Restrict TNF
Induced NF-kB Signals
(A) ELISA analyses of serum production of IL-6 andMCP-1
in mice of indicated genotypes after intraperitoneal injec-
tion of TNF. * indicates p < 0.05. Data are representative of
three independent experiments of three mice per geno-
type.
(B) qPCR analyses of A20 and IL-6 mRNA expression by
MEFs of indicated genotypes at indicated times after TNF
treatment. Data are normalized to actin mRNA. Data are
represented as means ± SD. Significant differences
(p < 0.05) present between WT/WT and both ZF4/ZF4 and
OTU/OTU mutant cells at 1 and 2 hr.
(C) Immunoblot analyses of A20, pIkBa, and IkBa
expression by MEFs of indicated genotypes at indicated
times after TNF treatment. Ratios of pIkba/IkBa expres-
sion are shown below as reflection of NF-kB signaling
activity for selected time points. Actin expression is shown
as loading control.
(D) IKK kinase assay using lysates from TNF inducedMEFs
of indicated genotypes at indicated time points. Quanti-
tation of pIkBa amounts normalized to IKKb expression in
IPs is shown below.
(E) Immunoblot analyses of JNK, p38, and pERK signaling
in TNF stimulated MEFs of indicated genotypes. See also
Figure S2.
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ZF4-Dependent Recruitment of A20 DimersTNF-stimulated A20/ cells with either GST-A20 or mutant
GST-A20ZF4 proteins and asked whether RIP1 molecules bound
to these A20 proteins. These experiments revealed that WTImmunity 38GST-A20 preferentially bound to ubiquitinated
rather than unmodified RIP1 proteins (compare
WT GST-A20 with input lysate, Figure 4B). By
contrast, A20ZF4 mutant proteins interacted
only with unmodified RIP1 proteins (Figure 4B).
Preferential coprecipitation of ubiquitinated
RIP1 proteins with WT A20 protein in these
assays was unlikely to reflect A20 ZF4 depen-
dent E3 ligase activity upon RIP1 as these
experiments were performed in the presence
of N-ethyl maleimide (NEM) at 4C, precluding
E3 ligase activity. These studies indicate that
A20 utilizes its ZF4 motif to bind ubiquitinated
RIP1.
To further investigate the recruitment of A20
proteins to TNFR signaling proteins, we
measured the recruitment of endogenous A20
proteins to TNFR complexes in Tnfaip3ZF4/ZF4,
Tnfaip3OTU/OTU, andWT cells. Despite being ex-
pressed at higher amounts than A20OTU andWT
A20 proteins, A20ZF4 proteins were recruited
poorly to TNFR complexes after TNF stimula-
tion (Figure 4C). By contrast, A20OTU proteins
are recruited nearly normally to TNFR com-
plexes (Figure 4C). Taken together, these find-
ings indicate that A20 uses its ZF4 motif to
bind ubiquitinated RIP1 in TNFR complexes.
Because poor recruitment of A20ZF4 proteins
to ubiquitinated TNFR signaling complexes
would prevent A20’s OTU-based DUB functionfrom removing ubiquitin chains from RIP1, this mechanism
can explain why Tnfaip3ZF4/ZF4 cells exhibit increased RIP1
ubiquitination., 896–905, May 23, 2013 ª2013 Elsevier Inc. 899
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Figure 3. A20’s OTU and ZF4 Motifs Restrict TNF Induced
RIP1 Ubiquitination
(A) Immunoblot analyses of RIP1 ubiquitination in TNFR IPs from indicated
cells at indicated time points after TNF treatment. TNFR protein expression in
IPs is shown below as control. Note higher molecular weight forms of RIP1
reflecting ubiquitinated RIP1.
(B) Immunoblot analysis of K48- and K63-linked ubiquitin chains on RIP1
molecules after sequential IP with first anti-TNFR and then anti-RIP1 (2) of
lysates from TNF-treated cells.
(C) Immunoblot analyses of TNFR IPs as in (B), with the exception that indi-
cated samples were treatedwithMG-132. Pre-IP quantities of RIP1 protein are
shown below as control. All experiments were performed at least three times.
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Figure 4. A20 Requires ZF4 to Bind K63-Linked Ubiquitin Chains and
Ubiquitinated RIP1
(A) Binding of recombinant GST-A20 proteins to recombinant K63-linked
ubiquitin chains. Recombinant C-terminal (aa 370–776) GST-WT and A20ZF4
mutant proteins were incubated with increasing concentrations of recombi-
nant K63-linked ubiquitin chains. Glutathione bead-bound proteins were then
analyzed by immunoblotting for ubiquitin (top panel). Immunoblot for GST
proteins are shown as controls (bottom panel).
(B) GST pull-down of ubiquitinated RIP1 from cell lysates. Cell lysates from
TNF stimulated A20/ MEFs were incubated with the indicated C-terminal
GST-A20 proteins, after which glutathione bead bound proteins were analyzed
by immunoblotting for RIP1. Input cell lysates are shown in right two lanes.
Immunoblot for GST proteins is shown below as controls (bottom panel).
(C) Recruitment of endogenous A20 proteins to TNFR signaling complexes.
MEFs of the indicated genotypes were stimulated with TNF for the indicated
times, immunoprecipitated with anti-TNFR antibody, and analyzed by immu-
noblotting for endogenous A20 proteins. Immunoblot for TNFR protein in IPs is
shown below as control. All experiments were performed at least two times.
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ZF4-Dependent Recruitment of A20 DimersA20OTU Proteins Complement A20ZF4 Proteins in Dimers
during TNF Responses of Tnfaip3OTU/ZF4 Compound
Mutant Cells
A20’s C103 based deubiquitination activity may be biochemi-
cally coupled to its ZF4-based E3 ubiquitin ligase activity. For
example, A20 might exchange K63-linked chains for K48 linked
chains on RIP1. To better understand how A20’s C103 and ZF4
motifs may coordinate A20’s ubiquitin-dependent functions, we
interbred Tnfaip3OTU/OTU with Tnfaip3ZF4/ZF4 mice and analy-
zed TNF responses of cells from the resulting compound
Tnfaip3OTU/ZF4 mice. Compound mutant Tnfaip3OTU/ZF4 cells
should express physiologically regulated A20 proteins divided
equally between A20OTU and A20ZF4 proteins. Compound
mutant Tnfaip3OTU/ZF4 mice exhibited less myeloid expansion900 Immunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc.than Tnfaip3ZF4 mice, suggesting that A20OTU complementation
of A20ZF4 proteins can also rescue TNF-dependent homeostasis
in vivo (Figure 5A). In contrast to either Tnfaip3OTU/OTU or
Tnfaip3ZF4/ZF4 mouse embryonic fibroblasts (MEFs), stimulation
of Tnfaip3OTU/ZF4 cells with TNF resulted in normal amounts of
the NF-kB-dependent mRNAs IL-6 and A20 over a variety of
TNF doses (Figure 5B). Thus, A20OTU proteins and A20ZF4
proteins complement each other in trans in Tnfaip3OTU/ZF4 cells.
The observation that A20OTU and A20ZF4 proteins complement
each other to normally regulate NF-kBsignaling in Tnfaip3OTU/ZF4
cells suggests that A20OTU proteins rescue the aberrant RIP1
ubiquitination and defective homing of A20ZF4 proteins observed
in Tnfaip3ZF4/ZF4 cells. To test this prediction, we assayed RIP1
ubiquitination in TNFR immunoprecipitates from Tnfaip3OTU/ZF4
as well as Tnfaip3ZF4/ZF4 and Tnfaip3OTU/OTU cells. These
experiments revealed that RIP1 ubiquitination in compound
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Figure 5. A20OTUMutant Proteins Rescue Recruitment Defects and NF-kB Signaling Defects of A20ZF4 Proteins in Compound Tnfaip3OTU/ZF4
MEFs
(A) Flow cytometric analyses of splenic myeloid cells from compound Tnfaip3OTU/ZF4 and control mice.
(B) Compound Tnfaip3OTU/ZF4 MEFs exhibit normal TNF responses. qPCR analyses of IL-6 and A20 mRNA expression in TNF treated MEFs of the indicated
genotypes. TNF doses are indicated. Error bars represent SDs.
(C) Compound Tnfaip3OTU/ZF4 cells rescue RIP1 ubiquitination, A20 recruitment, and NF-kB signaling defects seen in Tnfaip3ZF4/ZF4 cells. Immunoblot analyses of
TNFR-associated RIP1 ubiquitination and A20 recruitment in TNF-stimulated cells of the indicated genotypes after TNF stimulation for the indicated time points.
TNFR immunoblot of TNFR IP shown as IP loading control. Immunoblots of pIkBa and Ikba expression in pre-IPs shown as indicators of NF-kB signaling. Lines
represent means in (A); error bars represent mean ± SD in (B). All experiments were performed at least three times.
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ZF4-Dependent Recruitment of A20 Dimersmutant Tnfaip3OTU/ZF4 cells was reduced when compared to
Tnfaip3ZF4/ZF4 cells (Figure 5C). Thus, A20OTU and A20ZF4 pro-
teins collaborate to properly regulate RIP1 ubiquitination in
Tnfaip3OTU/ZF4 cells.
AsA20ZF4 proteins are recruitedpoorly to TNFRsignaling com-
plexes, the presence of normal NF-kB signaling in Tnfaip3OTU/ZF4
cells also raises the interesting possibility that A20OTU proteins
may dimerize with A20ZF4 proteins and recruit the latter to
TNFR signaling complexes in Tnfaip3OTU/ZF4 cells. Accordingly,
we tested the recruitment of A20 proteins to TNFR immunopre-
cipitates in TNF stimulated Tnfaip3OTU/ZF4, Tnfaip3ZF4/ZF4, and
Tnfaip3OTU/OTU cells. These experiments revealed that A20
proteins were recruited normally to TNFR complexes in
Tnfaip3OTU/ZF4 cells, in marked contrast to Tnfaip3ZF4/ZF4 cells
(Figure 5C, left panel). One possible interpretation of this result
is that A20OTU proteins, which exhibit normal recruitment to
TNFR, are selectively recruited to TNFR complexes in
Tnfaip3OTU/ZF4 cells. However, the kinetics of RIP1 ubiquitination
and NF-kB signaling in compound heterozygote Tnfaip3OTU/ZF4
cells were normal—in contrast to Tnfaip3OTU/OTU cells—suggest-
ing that A20 proteins at the TNFR complex in Tnfaip3OTU/ZF4 cells
are not predominantly A20OTU proteins (Figure 5C). The morelikely explanation for normal A20 protein recruitment and NF-kB
signaling in Tnfaip3OTU/ZF4 cells is that A20OTU proteins form
hetero-oligomers with A20ZF4 proteins, allowing the intact ZF4
domains of A20OTU proteins to recruit A20OTU/ZF4 oligomers to
TNFR complexes. The successful recruitment of A20OTU/ZF4 olig-
omers to TNFR signaling complexesmay then allow A20 to prop-
erly regulate RIP1 ubiquitination.
The apparent ability of A20OTU mutant proteins to recruit
A20ZF4 proteins to TNFR signaling complexes suggests that
A20 proteins dimerize under physiological conditions. To directly
test this idea, we transfectedWT or mutant A20 proteins bearing
distinct epitope tags into cells, immunoprecipitated with one tag
and immunoblotted with the alternative tag. These studies re-
vealed that full-length A20 proteins, including A20OTU and
A20ZF4 proteins, coprecipitated comparably as oligomers (Fig-
ure 6A). This result suggests that A20 proteins oligomerize in
cells in amanner that requires neither A20’s C103 nor its ZF4mo-
tifs. Thus, ZF4-mediated ubiquitin binding is not required for A20
oligomerization.
The oligomerization of A20 proteins in cells may involve a num-
ber of A20 binding partners. A20 proteinsmight also directly form
complexes in vitro. To test the latter hypothesis, we determinedImmunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc. 901
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Figure 6. A20 Proteins Form Dimers
(A) Coprecipitation of hemagglutinin (HA)-A20
proteins with FLAG-A20 proteins from cells.
Immunoprecipitation of HA-A20 followed by
immunoblotting of FLAG-A20 proteins from co-
transfected cells. Pre-IP expression of transfected
proteins are shown below as controls.
(B) Multiangle light scattering (MALS) analysis of
N-terminal (residues 1–370) A20 proteins. The
calculated mass of the His-A20 monomer is
45.5 kDa, and the measured mass is 89.6 kDa.
(C) Ribbon diagram of conserved dimers of
N-terminal A20 proteins. Distinct A20 monomers
are shown in magenta and cyan. a1 and a10 heli-
ces forming the intermolecular interface are
labeled.
(D) MALS analyses of N-terminal A20 proteins
bearing predicted dimerization mutations (M15A,
R16E, and M351A). Upper panel shows relative
light-scattering intensities (solid lines) and molec-
ular-mass distribution (dashed lines) of WT, A20
(residues 1–370), and indicated dimerization mu-
tants are plotted as functions of elution volume
(mL) on a Superdex 200 10/30 column. Lower
panel shows tabulated measured molecular mass,
experimental errors, and peak elution volumes of
WT and mutant A20 proteins. Experiments were
performed at least three times.
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ZF4-Dependent Recruitment of A20 Dimersthe molecular mass of recombinant A20 proteins by gel chroma-
tography and multi-angle light scattering (MALS). An N-terminal
A20 protein bearing the OTU domain (residues 1–370) formed di-
mers in solution with a measured mass of89 kDa, whereas the
calculated monomer mass of this protein is 45.5 kDa (Figure 6B).
Moreover, reexamination of the OTU portion of the A20 protein in
two crystal structures, P32 (Lin et al., 2008) and P21 (Komander
and Barford, 2008), revealed that there were six and four mole-
cules, respectively, per crystallographic asymmetric unit. These
ten molecules formed five conserved dimers, with interfaces
formed mostly by the a1 and a10 helices of the OTU structure
(Table 1; Figure 6C). The dimer interface is extensive, burying
800A˚2 surface areas per monomer. Residues that bury the
largest surface areas include M15, R16, and H351, and mutation
of these residues, M15 to alanine (M15A), R16 to glutamate
(R16E), or H351 to alanine (H351A), compromised A20 dimeriza-
tion, with H351A having themost drastic effect (Figure 6D). Thus,
A20 proteins directly form homodimers. Taken together, these
findings indicate that A20’s ZF4 motif recruits A20 dimers to
ubiquitinated RIP1 signaling complexes during TNF signaling.
These dimers may bring multiple copies of A20’s ubiquitin modi-
fying activities, as well as potential binding partners, to ubiquiti-
nated complexes.
DISCUSSION
Our studies of Tnfaip3ZF4/ZF4, Tnfaip3OTU/OTU, and Tnfaip3OTU/ZF4
compound mutant mice reveal several facets of A20’s regulation
of TNF signaling. We have discovered a role for A20’s ZF4 motif
in recruiting A20 proteins to ubiquitinated RIP1 during TNF
signaling. We have found that A20’s C103 and ZF4 mutant pro-
teins complement each other in cells. This complementation is
facilitated by dimerization of A20 proteins, and we have defined902 Immunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc.a dimerization interface in A20. These motifs perform distinct
biochemical functions in regulating TNF signals.
Although prior studies suggested that A20’s N-terminal OTU
domain is not required for A20’s ability to restrict TNF signals,
our current experiments demonstrate that A20’s C103 based
DUB activity restricts TNF induced signals (Song et al., 1996,
Heyninck and Beyaert, 1999). Our serial TNFR and RIP1 IP ex-
periments with Tnfaip3OTU/OTU cells revealed that RIP1 proteins
bear increased amounts of both K48- and K63-linked ubiquitin
chains in Tnfaip3OTU/OTU cells, suggesting that A20’s DUB activ-
ity removes both types of chains fromRIP1 in cells. These chains
might be removed together if they are present in mixed K48- and
K63- linked ubiquitin chains. Distinguishing these physiological
chain conformations will require more biochemically detailed
analyses of physiological signaling complexes.
A20’s C103 may also support degradation of Ubc5hc and
Ubc13 proteins approximately 4–6 hr after TNF stimulation
(Shembade et al., 2010). This function of A20’s C103 appears
temporally distinct from themore acute differences in RIP1 ubiq-
uitination we have observed 10–15min after TNF stimulation. We
have not observed differences in expression of these
E2 enzymes in Tnfaip3OTU/OTU cells at acute time points (e.g.,
10–15 min) (data not shown). Nor have we observed acute
recruitment defects of A20OTU proteins to TNFR signaling com-
plexes. Hence, A20’s C103 acute functions regulating RIP1 ubiq-
uitination appear distinct from apparently later functions
regulating E2 enzyme stability. The net physiological function
of A20’s C103 vis a vis RIP1 is to limit both K48 and K63 ubiqui-
tination of this protein. Failure to perform this function leads to
increased IKK activation and NF-kB signaling.
A20’s ZF4 is a complex motif that has been shown to bind
ubiquitin, build K48 ubiquitin chains on RIP1, and support degra-
dation of E2 enzymes (Wertz et al., 2004, Bosanac et al., 2010,
Table 1. A20 OTU Domains Form Conserved Dimers in Crystal
Structures
3DKB, chains C and F
3DKB, chains A and D 704 aligned Ca, 0.40 A˚
3DKB, chains B and E 704 aligned Ca, 0.44 A˚
2VFJ, chains A and D 623 aligned Ca, 1.1 A˚
2VFJ, chains B and C 623 aligned Ca, 0.75 A˚
Structure-based alignments among the three A20 dimers in the PDB co-
ordinates 3DKB and the two A20 dimers in the PDB coordinates 2VFJ are
shown.
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ZF4-Dependent Recruitment of A20 DimersShembade et al., 2010). Our results reveal that A20’s ZF4 is crit-
ical for mediating A20’s recruitment to ubiquitinated RIP1 in
TNFR signaling complexes. Thus, A20’s ZF4 may support
several functions for A20. One potential mechanism by which
this motif might support several functions would be to collabo-
rate with other A20 motifs, including other A20 zinc fingers, to
bind different ubiquitinated molecules. For example, A20’s ZF1
and ZF2 appear to support binding to RIP1, whereas A20’s
ZF7 binds linear and K63-linked polyubiquitin chains (Skaug
et al., 2011, Tokunaga et al., 2012, Verhelst et al., 2012).
Although the principles by which ubiquitin-binding proteins
recognize distinct substrates are poorly understood, recent
studies suggest that these proteins can recognize distinct con-
formations of ubiquitin chains via multiple ubiquitin binding mo-
tifs (Sims and Cohen, 2009; Sims et al., 2009). Thus, A20’s ZF4
motif may contribute to A20’s binding to ubiquitinated E2, ubiq-
uitinated RIP1, and potentially other ubiquitinated species.
Our observation of increased K48 ubiquitinated RIP1 in
A20ZF4/ZF4 cells–even in the presence of proteasome inhibi-
tion–was an unexpected finding given A20’s ZF4 mediated
support of E3 ligase function building K48 chains. The most
straightforward interpretation of our findings is that A20ZF4 pro-
teins fail to bind ubiquitinated RIP1 in TNFR signaling complexes
and thus fail to deubiquitinate ubiquitinated RIP1 in these com-
plexes. As the net effect of A20’s ZF4 mutation on RIP1 ubiquiti-
nation is increased—rather than diminished—ubiquitination, the
predominant physiological function of this motif is to limit RIP1
ubiquitination during TNF signaling. In addition, our studies indi-
cate that other E3 ligases such as cIAPs or TRAFs likely build
ubiquitin chains on RIP1 during TNF signaling. Future studies
may unveil greater complexities in types of chains and ubiquiti-
nation sites on RIP1. A combination of recruitment and E3 ligase
functions may contribute to A20’s ZF4’s roles in regulating RIP1
ubiquitination. Overall, our studies unveil a critical role for A20’s
ZF4 in recruiting A20 to ubiquitinated RIP1 independently of its
role in supporting E3 ligase activity.
Our studies of compound mutant Tnfaip3OTU/ZF4 cells reveal
that A20 proteins dimerize in vivo. Successful recruitment of
A20OTU and A20ZF4 proteins to the TNFR signaling complex in
these cells indicates that A20 proteins require neither C103 nor
ZF4 motifs to dimerize, and these dimers require only a single
intact ZF4 motif to be recruited to TNFR signaling complexes.
These findings suggest that coordination between A20’s deubi-
quitinating, E3 ligase, and ubiquitin-binding functions occur in
higher-order complexes rather than within a single A20 mole-
cule. Oligomerization of signaling complexes has emerged asan important principle in propagating activating signals (Krapp-
mann and Scheidereit, 2005). Our studies indicate that oligomer-
ization of negative regulatory enzymes may also be a general
theme.
Our observations of A20 oligomers in cells led us to discover
that A20 proteins form dimers with extensive interfaces.
Biochemical identification of A20’s oligomerization and recruit-
ment motifs provides additional opportunities for the regulation
of A20’s functions. Dimerization of the ubiquitin hydrolase
UCH-L1 influences its ability to function as a ligase, so dimeriza-
tion of A20 may also regulate its enzymatic functions (Liu et al.,
2002). Further studies of A20 proteins should reveal important
insights into how A20 coordinates its ubiquitin modifying
functions.
A20’s C103 and ZF4 motifs have been associated with A20’s
repression of TNF-induced NF-kB signals (Wertz et al., 2004,
Shembade et al., 2010). Thus, Tnfaip3OTU and A20ZF4 micemight
be expected to resemble Tnfaip3/ mice (Lee et al., 2000).
However, Tnfaip3/ mice develop spontaneous multiorgan
inflammation and perinatal lethality, whereas both Tnfaip3OTU
and Tnfaip3ZF4 mice exhibit little spontaneous disease. Because
these mice have all been analyzed on inbred C57BL/6J back-
grounds in the same facility, these differences are unlikely to
be strain or environment related. One potential explanation for
this difference is that A20’s DUB and E3 ligase activities partly
compensate for each other in vivo, so that mice expressing dou-
ble-mutant A20 proteins (i.e., OTU and ZF4 mutations within the
same protein) would more closely resemble A20/ mice.
Because A20’s C103 and ZF4 motifs are obviously tightly linked
genetically, additional gene-targeting studies will be necessary
to investigate these possibilities. Another explanation could be
that other motifs of A20 perform critical functions that are impor-
tant for regulating NF-kB signals and preserving immune homeo-
stasis. For example, A20’s ZF7 has recently been described to
restrict NF-kB signaling at the IKKg complex, and this function
involves binding of ZF7 to linear ubiquitin chains (Skaug et al.,
2011, Tokunaga et al., 2012, Verhelst et al., 2012). In sum, the
distinct functions of A20’s C103 and ZF4 motifs imply that they
may impart distinct immune perturbations and disease suscep-
tibilities. These functions may provide important insight into how
A20 regulates diverse NF-kB signals (Baltimore, 2011, Ma and
Malynn, 2012). Given the variety of coding and noncoding A20
mutations that have been described in human diseases, under-
standing A20’s functions will be crucial for deciphering the path-
ophysiology of these diseases.
EXPERIMENTAL PROCEDURES
Generation of Tnfaip3OTU and Tnfaip3ZF4 Mice
To generate gene A20OTU and A20ZF4 mice, we utilized two distinct bacterial
artificial chromosomes (BACs) bearing the A20 gene from the C57BL/6J strain.
Site-directed mutagenesis was used to change the catalytic cysteine at amino
acid 103 to an alanine to generate the OTUmutant gene targeting construct. In
a separate construct, two cysteines (C609, C612) in A20’s ZF4 were mutated
to alanines to generate the ZF4 gene targeting construct. These targeting con-
structs were transfected into PRXB6T (C57BL/6J) embryonic stem (ES) cells.
Properly targeted ES cell clones from both constructs were identified by
Southern analysis and transiently transfected with a plasmid expressing Cre
enzyme to delete the floxed neomycin cassettes. Blastocyst injections of tar-
geted ESCs were performed by the UCSF Transgenic Core. Chimeric mice
were bred with C57BL/6J mice to obtain Tnfaip3ZF4 and Tnfaip3OTU mice onImmunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc. 903
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ZF4-Dependent Recruitment of A20 Dimersan inbred C57BL/6J background. All mouse handling was done according to
the UCSF’s institutional guidelines.
Flow Cytometry and ELlSA
Cell preparations and flow cytometric and ELISA analyses were performed as
previously described (Tavares et al., 2010). All antibodieswere purchased from
BD Biosciences. Cells were analyzed by flow cytometry by using LSRII
(BD Biosciences) and Flowjo software (Tree Star).
Cell Signaling Assays
MEFs were derived from Tnfaip3OTU/OTU, Tnfaip3ZF4/AF4, and Tnfaip3OTU/ZF4
embryos as previously described (Oshima et al., 2009). MEFs were stimulated
with 10 ng/ml TNF and lysed in lysis buffer (20 mM Tris HCl pH 7.4, 150 mM
NaCl, 10% glycerol, 0.2% NP-40 supplemented with Roche protease inhibi-
tors, phosphatase inhibitors (1 mM NaV, 5 mM NaF, 20 mM b-glycerol phos-
phate), and 10 mM N-ethylmaleimide. Cells were lysed on ice for 20 min,
and cleared by centrifugation at 14,000 rpm for 20 min. For immunoprecipita-
tion of the TNF receptor complex, cells were stimulated and lysed as above.
Supernatants were immunoprecipitated with anti-TNFR antibody (R and D)
and Protein G Dynabeads.
For the IKK kinase assay of TNF-treatedMEFs, total cell lysates from repeat-
edly TNF-treated MEFs were immunoprecipitated with an anti-IKKg antibody,
and kinase activity was assessed by using a GST-IkBa substrate. Comparable
IKKb protein in immunoprecipitated samples was confirmed by immunoblot.
Serial IP Analyses of RIP1 Ubiquitination
For sequential immunoprecipitation, cells were lysed in lysis buffer supple-
mented with 10 mM MG-132 as above. For the primary immunoprecipitation,
TNFR complexes were immunoprecipitated and washed twice with lysis
buffer, twice with lysis buffer supplemented with 1M NaCl, and twice with lysis
buffer. TNFR complexes were denatured and eluted with lysis buffer contain-
ing 6M Urea. Eluates were diluted 1:25 and immunoprecipitated with an anti-
RIP antibody overnight at 4C. Immune complexes were collected with protein
G dynabeads, extensively washed, and analyzed by immunoblot. Antibodies
used included: anti-RIP1 (BD 610459, Cell Signal 3493), anti-A20 (Cell Signal
5630), anti-TNFR (R and D AF-425-PB, Abcam 19139), anti-pIkba (Cell Signal
9246), anti-Ikba (Cell Signal 9242), anti-K63 ubiquitin (Millipore 05-1307), anti-
K48 ubiquitin (Millipore 05-1308), and anti-Ub (P4D1, SCBT).
Ubiquitin-Binding Assays
Ubiquitin binding of A20 proteins was performed by incubating recombinant
GST-A20 proteins with recombinant ubiquitin chains followed by immunoblot-
ting analyses. Binding studies of A20 to ubiquitinated RIP1 were perfomed by
incubating whole cell lysates from TNF stimulated A20/MEFs with recombi-
nant GST-A20 proteins.
DSS Colitis
Sex-matched WT, Tnfaip3OTU/OTU, and Tnfaip3ZF4/AF4 mice between 2 and
3 months of age were cohoused and exposed to drinking water with 3% DSS
(MP Biomedicals) for 5 days. Tissues samples were taken 6 days after removal
of DSS for histological and mRNA analysis. The degree of inflammation in the
colon was graded according to a previously described grading system that
evaluates inflammatory cell infiltration and tissue damage (Onizawa et al.,
2009). Briefly, the scoring for inflammatory cell infiltration is as follows: 0,
occasional inflammatory cells in the lamina propia; 1, increased numbers of in-
flammatory cells in the lamina propria; 2, confluence of inflammatory cells, ex-
tending into the submucosa; 3, transmural extension of the infiltrate. Tissue
damagewas scored as follows: 0, nomucosal damage; 1, discrete lymphoepi-
thelial lesions; 2, surface mucosal erosion or focal ulceration; 3, extensive
mucosal damage and extension into deeper structures of the bowel wall. The
combined histological score ranged from 0 (no changes) to 6 (extensive cell
infiltration and tissue damage).
RNA Analyses
RNA was isolated from stimulated cells and reverse transcribed (Applied Bio-
systems). Taqman gene expression master mix and Taqman gene expression
assay primers from Applied Biosystems were used for quantitative real time904 Immunity 38, 896–905, May 23, 2013 ª2013 Elsevier Inc.PCR on an ABI 7300 (Applied Biosystems). Relative mRNA units were calcu-
lated as 2^-(CT gene of interest – CT actin).
Multi-Angle Light Scattering (MALS) Analyses
The molar mass of A20 protein complexes (residues x-y, or 1–370) was deter-
mined byMALS. Protein sample was injected into a Superdex 200 (10/300 GL)
gel filtration column (GE Healthcare) equilibrated in a buffer containing 20 mM
Tris at pH 8.0 and 150 mM NaCl. The chromatography system was coupled to
a three-angle light scattering detector (mini-DAWN TRISTAR) and a refractive
index detector (Optilab DSP) (Wyatt Technology). Data were collected every
0.5 s with a flow rate of 0.2 mL/min. Data analysis was carried out by using
ASTRA V.
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